The abstract is read at the publisher; the summary is JClub's.
In a national Medicare-linked RISE cohort of 45,455 older adults with rheumatic diseases, 30.7% received at least one high-risk medication, with prescriptions mostly from non-rheumatology clinicians (82.3%).
- Why it matters: Older adults with rheumatic disease often have multi-morbidity and polypharmacy, creating elevated risk for adverse events from high-risk medications, yet prescribing patterns and patient drivers are not well quantified.
- What they did: Using RISE registry data from practices covering about one-third of U.S. rheumatologists and linked Medicare Parts A, B, and D, the study modeled HRM prescribing with logistic regression and generalized estimating equations.
- The result: After adjustment, axial spondyloarthritis (OR 1.40, 95%CI 1.20-1.62) and Sjögren's disease (OR 1.39, 95%CI 1.04-1.86) showed the highest odds of HRM prescribing versus rheumatoid arthritis, supporting targeted medication review and cross-specialty collaboration.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.